THOMAS F. DEUEL, M.D.

Corporate Board Profile

Tech Score: 0/100

ENZON PHARMACEUTICALS, INC.

Filing Date	Source Excerpt
2010-06-10	Thomas F. Deuel, M.D. has served as a director of the Company since April 2010. Dr. Deuel is currently a Professor of Molecular and Experimental Medicine and Cell Biology, Director of the Division of Molecular Oncology, Department of Molecular and Experimental Medicine, and Director of the Vascular Biology Affinity Group at The Scripps Research Institute and has served in such positions since February 2002.

Filing Date

Source Excerpt

2010-06-10

Thomas F. Deuel, M.D. has served as a director of the Company since April 2010. Dr. Deuel is currently a Professor of Molecular and Experimental Medicine and Cell Biology, Director of the Division of Molecular Oncology, Department of Molecular and Experimental Medicine, and Director of the Vascular Biology Affinity Group at The Scripps Research Institute and has served in such positions since February 2002.

Data sourced from SEC filings. Last updated: 2025-10-12